A phase II, open label, randomized controlled trial of nivolumab plus ipilimumab with stereotactic radiotherapy versus ipilimumab plus nivolumab alone in patients with melanoma brain metastases (ABC -X Trial).

被引：11
作者：
Gonzalez, Maria
Hong, Angela M.
Carlino, Matteo S.
Atkinson, Victoria
Wang, Wei
Lo, Serigne
Brown, Michael Paul
Foote, Matthew C.
Pinkham, Mark B.
Le, Hien
Roos, Daniel E.
Osorio, Monica
Haghighi, Neda
Kok, David
Postow, Michael A.
McArthur, Grant A.
Menzies, Alexander M.
Long, Georgina V.
机构：
[1] Melanoma Inst Australia, Sydney, NSW, Australia
[2] Univ Sydney, Chris OBrien Lifehouse, Melanoma Inst Australia, Sydney, NSW, Australia
[3] Univ Sydney, Westmead Hosp, Sydney, NSW, Australia
[4] Univ Sydney, Blacktown Hosp, Melanoma Inst Australia, Sydney, NSW, Australia
[5] Univ Queensland, Gallipoli Med Res Fdn, Princess Alexandra Hosp, Woolloongabba, Qld, Australia
[6] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
[7] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[8] Royal Adelaide Hosp, Adelaide, SA, Australia
[9] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia
[10] Univ Queensland, Queensland Univ Technol, Gamma Knife Ctr Queensland, Princess Alexandra Hosp, Woolloongabba, Qld, Australia
[11] Univ Adelaide, Royal Adelaide Hosp, Adelaide, SA, Australia
[12] Melanoma Inst Australia, Sydney, NSW, Australia
[13] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[15] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[16] Univ Sydney, Melanoma Inst Australia, Royal North Shore Hosp, Sydney, NSW, Australia
[17] Royal North Shore Hosp, Sydney, NSW, Australia
[18] Mater Hosp, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.TPS9600
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9600
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
    Vos, Joris L.
    Burman, Bharat
    Jain, Swati
    Fitzgerald, Conall W. R.
    Sherman, Eric J.
    Dunn, Lara A.
    Fetten, James V.
    Michel, Loren S.
    Kriplani, Anuja
    Ng, Kenneth K.
    Eng, Juliana
    Tchekmedyian, Vatche
    Haque, Sofia
    Katabi, Nora
    Kuo, Fengshen
    Han, Catherine Y.
    Nadeem, Zaineb
    Yang, Wei
    Makarov, Vladimir
    Srivastava, Raghvendra M.
    Ostrovnaya, Irina
    Prasad, Manu
    Zuur, Charlotte L.
    Riaz, Nadeem
    Pfister, David G.
    Klebanoff, Christopher A.
    Chan, Timothy A.
    Ho, Alan L.
    Morris, Luc G. T.
    NATURE MEDICINE, 2023, 29 (12) : 3077 - 3089
  • [42] Phase II Study of Nivolumab Plus Ipilimumab with Chemotherapy for Advanced NSCLC with Untreated Brain Metastases: NIke Trial (LOGiK2004)
    Tsuchiya-Kawano, Y.
    Shiraishi, Y.
    Tachihara, M.
    Saito, R.
    Okamoto, T.
    Sugasaki, N.
    Nakatomi, K.
    Kiyomi, F.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S156 - S156
  • [43] Nivolumab plus ipilimumab (NI) versus chemotherapy plus nivolumab (CN) in squamous cell lung cancer (SqCLC): The SQUINT trial
    Landi, L.
    Bonanno, L.
    Delmonte, A.
    Maximilian, P.
    Stati, V.
    Minotti, V.
    Bennati, C.
    D'Inca, F.
    Migliorino, M. R.
    Gori, S.
    Santo, A.
    Piantedosi, F.
    Russo, A.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] Ipilimumab plus nivolumab in patients with symptomatic melanoma brain metastasis requiring corticosteroids
    Manacorda, Simona
    Carmena, Maria De Toro
    Malone, Ciara
    Le, Ha Mo Linh
    Furness, Andrew J. S.
    Larkin, James
    Schmitt, Andreas M.
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 98 - 107
  • [45] Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma A Randomized Clinical Trial
    Hodi, F. Stephen
    Lee, Sandra
    McDermott, David F.
    Rao, Uma N.
    Butterfield, Lisa H.
    Tarhini, Ahmad A.
    Leming, Philip
    Puzanov, Igor
    Shin, Donghoon
    Kirkwood, John M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (17): : 1744 - 1744
  • [46] Nivolumab Plus Ipilimumab (NI) Versus Chemotherapy Plus Nivolumab (CN) in Squamous Cell Lung Cancer (SqCLC): The SQUINT Trial
    Landi, L.
    Bonanno, L.
    Delmonte, A.
    Papi, M.
    Stati, V.
    Minotti, V.
    Bennati, C.
    D'Inca, F.
    Migliorino, M.
    Gori, S.
    Santo, A.
    Piantedosi, F.
    Russo, A.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S727 - S727
  • [47] Phase II trial of ipilimumab monotherapy in melanoma patients with brain metastases
    Lawrence, D. P.
    Hamid, O.
    McDermott, D. F.
    Puzanov, I.
    Sznol, M.
    Clark, J.
    Logan, T.
    Hodi, F. S.
    Heller, K. N.
    Margolin, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Phase II trial of ipilimumab monotherapy in melanoma patients with brain metastases
    Lawrence, D.
    Hamid, O.
    McDermott, D.
    Puzanov, I
    Sznol, M.
    Clark, J.
    Logan, T.
    Hodi, F. S.
    Heller, K. N.
    Margolin, K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (09): : 763 - 764
  • [49] A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial).
    Bagge, Roger Olofsson
    Nelson, Axel
    Shafazand, Amir
    Cahlin, Christian
    Carneiro, Ana
    Helgadottir, Hildur
    Levin, Max
    Rizell, Magnus
    Ullenhag, Gustav J.
    Wiren, Sara
    Lindner, Per
    Nilsson, Jonas A.
    Ny, Lars
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
    Hodi, F. Stephen
    Chesney, Jason
    Pavlick, Anna C.
    Robert, Caroline
    Grossmann, Kenneth F.
    McDermott, David F.
    Linette, Gerald P.
    Meyer, Nicolas
    Giguere, Jeff Rey K.
    Agarwala, Sanjiv S.
    Shaheen, Montaser
    Ernstoff, Marc S.
    Minor, David R.
    Salama, April K.
    Taylor, Matthew H.
    Ott, Patrick A.
    Horak, Christine
    Gagnier, Paul
    Jiang, Joel
    Wolchok, Jedd D.
    Postow, Michael A.
    LANCET ONCOLOGY, 2016, 17 (11) : 1558 - 1568
12345